Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Lori Pierce

Breast Rad Onc · UM

View

Dr. Drew Moghanaki

Thoracic Rad Onc · UCLA

View

Dr. Himanshu Nagar

GU Rad Onc · MSK

View

Dr. Michael Dykstra

General Rad Onc · UM

View

Dr. William Hwang

GI Rad Onc · MGH

View

Dr. James Janopaul-Naylor

GU Rad Onc · MSK

View

Dr. Philip Schauer

Bariatric Surgery · PBRC

View

Dr. Justin Hovey, FAAP, FACP, DABOM

Obesity Medicine · Noland Hospital Dothan II

View

Dr. Kimberly Gudzune

Obesity Medicine · JHU

View

Dr. Richard Dutton

General Anesthesiology · UMSOM

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    KADr. Kamran Ahmed
    Leading Voice

    Dr. Kamran Ahmed

    Radiation Oncology · Breast Radiation Oncology
    Moffitt Cancer Center
    kamran

    Research

    Phase II trial of brain MRI surveillance in stage IV breast cancer

    2025

    Via Neuro-oncology

    Research

    Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib study

    2025

    Via Journal for immunotherapy of cancer

    Research

    Association between transcriptomic metrics of exogenous antigen presentation and adaptive immunity with locoregional recurrence in localized estrogen receptor negative breast cancer: retrospective review of multi-institutional datasets

    2025

    Via Breast cancer research : BCR

    Research

    Atezolizumab and Stereotactic Body Radiation in Metastatic, Recurrent, or Persistent Cervical Cancer: Results From a Phase 2 Multi-Institutional Study

    2025

    Via International journal of radiation oncology, biology, physics

    Research

    Definitive intensity-modulated radiotherapy for organ preservation in vulvar cancer: A multicenter study

    2025

    Via Gynecologic oncology

    Jul 23, 2025Adaptive Clinical Trial

    Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial.

    ​
    ​
    ​+3

    Written by 5 Roon authors & 34 others

    Via Annals of Surgical Oncology

    Research

    Phase IB Study of Avelumab and Whole Brain Radiotherapy (WBRT) in Patients with Leptomeningeal Disease (LMD) from Solid Tumors: Results and Molecular Analyses

    2025

    Via Neuro-oncology

    Research

    Sacituzumab govitecan and stereotactic radiosurgery in the management of HER2 negative breast cancer brain metastases: a multi-institutional report

    2025

    Via Journal of neuro-oncology

    Research

    Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery

    2024

    Via Journal of neuro-oncology

    Research

    Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma

    2024

    Via BMC cancer

    Research

    Clinical Outcomes of Patients with Non-Small Cell Lung Cancer Leptomeningeal Disease Following Receipt of EGFR-Targeted Therapy, Immune-Checkpoint Blockade, Intrathecal Chemotherapy, or Radiation Therapy Alone

    2024

    Via Clinical lung cancer

    Research

    Radiation Therapy Followed by Intrathecal Trastuzumab-Pertuzumab for ERBB2-Positive Breast Leptomeningeal Disease: A Phase 1 Nonrandomized Controlled Trial

    2024

    Via JAMA oncology

    Research

    Controversies in neuro-oncology: Focal proton versus photon radiation therapy for adult brain tumors

    2024

    Via Neuro-oncology practice

    Research

    Prediction of radiologic outcome-optimized dose plans and post-treatment magnetic resonance images: A proof-of-concept study in breast cancer brain metastases treated with stereotactic radiosurgery

    2024

    Via Physics and imaging in radiation oncology

    Research

    Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases

    2024

    Via NPJ breast cancer